Biotech · Private company
Alebund Pharmaceuticals
Track this companyFree. Adds Alebund Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- AP301Phase 3 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- AP301 Low DosePhase 3 · HyperphosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With HyperphosphatemiaPHASE2 · RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT06712654 · fetched Nov 12, 2026
- A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and ChinaPHASE3 · RECRUITING · started Jun 13, 2025ClinicalTrials.gov NCT06933472 · fetched Nov 12, 2026